2LZ3 - Header Asymmetric Unit

HEADER MEMBRANE PROTEIN 23-SEP-12 2LZ3

TITLE SOLUTION NMR STRUCTURE OF TRANSMEMBRANE DOMAIN OF AMYLOID PRECURSOR TITLE 2 PROTEIN WT

COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMYLOID BETA A4 PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PETM41

KEYWDS HELIX, DIMER, TRANSMEMBRANE, MEMBRANE PROTEIN

EXPDTA SOLUTION NMR

NUMMDL 21

MDLTYP MINIMIZED AVERAGE

AUTHOR W.CHEN,C.WANG

REVDAT 4 27-APR-16 2LZ3 1 REMARK SEQRES REVDAT 3 05-FEB-14 2LZ3 1 JRNL REVDAT 2 18-DEC-13 2LZ3 1 JRNL REVDAT 1 02-OCT-13 2LZ3 0

JRNL AUTH W.CHEN,E.GAMACHE,D.J.ROSENMAN,J.XIE,M.M.LOPEZ,Y.M.LI,C.WANG JRNL TITL FAMILIAL ALZHEIMER'S MUTATIONS WITHIN APPTM INCREASE A BETA JRNL TITL 2 42 PRODUCTION BY ENHANCING ACCESSIBILITY OF EPSILON-CLEAVAGE JRNL TITL 3 SITE. JRNL REF NAT COMMUN V. 5 3037 2014 JRNL REFN ESSN 2041-1723 JRNL PMID 24390130 JRNL DOI 10.1038/NCOMMS4037

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.CHEN,E.GAMACHE,D.RICHARDSON,Z.DU,C.WANG REMARK 1 TITL EXPRESSION, PURIFICATION, AND RECONSTITUTION OF THE REMARK 1 TITL 2 TRANSMEMBRANE DOMAIN OF THE HUMAN AMYLOID PRECURSOR PROTEIN REMARK 1 TITL 3 FOR NMR STUDIES. REMARK 1 REF PROTEIN EXPR.PURIF. V. 81 11 2012 REMARK 1 REFN ISSN 1046-5928 REMARK 1 PMID 21907289 REMARK 1 DOI 10.1016/J.PEP.2011.08.006

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER, A.T. ET AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: TWO RDC MEDIA

REMARK 4 REMARK 4 2LZ3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-SEP-12. REMARK 100 THE RCSB ID CODE IS RCSB103006.

REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 313 REMARK 210 PH : 7.2 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-100% 13C; U-100% 15N] REMARK 210 PEPTIDE, SODIUM PHOSPHATE, 10% REMARK 210 D2O; 0.5 MM [U-100% 13C; U-100% REMARK 210 15N] PEPTIDE, SODIUM PHOSPHATE, REMARK 210 100% D2O; 0.5 MM [U-99% 15N] REMARK 210 PEPTIDE, SODIUM PHOSPHATE, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCO; 3D HNCACB; 3D HBHA(CO) REMARK 210 NH; 3D H(CCO)NH; 3D HCCH-TOCSY; REMARK 210 3D 1H-15N NOESY; 3D 1H-15N TOCSY; REMARK 210 3D 1H-13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 21 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL

REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-21 REMARK 465 RES C SSSEQI REMARK 465 ALA A 2 REMARK 465 MET A 3 REMARK 465 ALA A 4 REMARK 465 ALA B 2 REMARK 465 MET B 3 REMARK 465 ALA B 4

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 VAL A 16 -18.72 -49.05 REMARK 500 1 VAL B 16 -18.60 -49.08 REMARK 500 2 VAL A 16 -19.57 -47.11 REMARK 500 2 VAL B 16 -19.64 -47.19 REMARK 500 3 VAL A 16 -18.31 -45.75 REMARK 500 3 VAL B 16 -18.44 -45.88 REMARK 500 4 VAL A 16 -19.02 -46.88 REMARK 500 4 VAL B 16 -19.03 -46.83 REMARK 500 5 VAL A 16 -19.19 -47.43 REMARK 500 5 VAL B 16 -19.15 -47.50 REMARK 500 6 VAL A 16 -19.33 -46.99 REMARK 500 6 VAL B 16 -19.13 -47.12 REMARK 500 8 VAL A 16 -18.02 -46.86 REMARK 500 8 VAL B 16 -18.00 -46.88 REMARK 500 9 VAL A 16 -16.84 -45.92 REMARK 500 9 VAL B 16 -16.92 -45.95 REMARK 500 10 VAL A 16 -19.77 -45.56 REMARK 500 10 VAL B 16 -19.85 -45.59 REMARK 500 11 VAL A 16 -16.72 -44.70 REMARK 500 11 VAL B 16 -16.74 -44.94 REMARK 500 12 VAL A 16 -19.18 -47.00 REMARK 500 12 VAL B 16 -19.20 -47.00 REMARK 500 13 VAL A 16 -19.37 -46.40 REMARK 500 13 VAL B 16 -19.47 -46.39 REMARK 500 14 VAL A 16 -17.82 -47.26 REMARK 500 14 VAL B 16 -17.90 -47.02 REMARK 500 15 VAL A 16 -17.68 -46.91 REMARK 500 15 VAL B 16 -17.71 -46.85 REMARK 500 16 VAL A 16 -17.35 -49.50 REMARK 500 16 VAL B 16 -17.34 -49.30 REMARK 500 17 VAL A 16 -16.50 -46.39 REMARK 500 17 VAL B 16 -16.91 -46.50 REMARK 500 18 ILE A 18 -19.93 -41.82 REMARK 500 18 LYS A 31 18.44 -150.62 REMARK 500 18 ILE B 18 -19.79 -42.14 REMARK 500 18 LYS B 31 19.29 -151.02 REMARK 500 20 VAL A 16 -18.14 -47.24 REMARK 500 20 VAL B 16 -18.16 -47.24 REMARK 500 21 VAL A 16 -18.79 -49.17 REMARK 500 21 VAL B 16 -18.64 -48.72 REMARK 500 REMARK 500 REMARK: NULL

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18649 RELATED DB: BMRB REMARK 900 RELATED ID: 2LZ4 RELATED DB: PDB

DBREF 2LZ3 A 5 32 UNP P05067 A4_HUMAN 699 726 DBREF 2LZ3 B 5 32 UNP P05067 A4_HUMAN 699 726

SEQADV 2LZ3 ALA A 2 UNP P05067 EXPRESSION TAG SEQADV 2LZ3 MET A 3 UNP P05067 EXPRESSION TAG SEQADV 2LZ3 ALA A 4 UNP P05067 EXPRESSION TAG SEQADV 2LZ3 ALA B 2 UNP P05067 EXPRESSION TAG SEQADV 2LZ3 MET B 3 UNP P05067 EXPRESSION TAG SEQADV 2LZ3 ALA B 4 UNP P05067 EXPRESSION TAG

SEQRES 1 A 31 ALA MET ALA LYS GLY ALA ILE ILE GLY LEU MET VAL GLY SEQRES 2 A 31 GLY VAL VAL ILE ALA THR VAL ILE VAL ILE THR LEU VAL SEQRES 3 A 31 MET LEU LYS LYS LYS SEQRES 1 B 31 ALA MET ALA LYS GLY ALA ILE ILE GLY LEU MET VAL GLY SEQRES 2 B 31 GLY VAL VAL ILE ALA THR VAL ILE VAL ILE THR LEU VAL SEQRES 3 B 31 MET LEU LYS LYS LYS

HELIX 1 1 LYS A 5 VAL A 16 1 12 HELIX 2 2 VAL A 17 LYS A 31 1 15 HELIX 3 3 GLY B 6 VAL B 16 1 11 HELIX 4 4 VAL B 17 LYS B 31 1 15

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000